Shares of GlaxoSmithKline $GSK are up more than 3% this morning after the company rejected an unsolicited $68 billion takeover offer from Unilever for its consumer healthcare goods unit. @HathornSabin looks at the chart. #trading
68% of retail CFD accounts lose money. pic.twitter.com/zLhsvueFeO

— IG (@IGcom) January 17, 2022